Semperit AG Holding Reports Financial Results for 2023, Eyes Growth Despite Challenges

Vienna, March 19, 2024 – Semperit AG Holding has reported its financial results for the year 2023, demonstrating resilience in a tough economic environment. Despite a 7.5% decrease in revenue to EUR 721.1 million and a marked impact from the divested medical business, the company is positioned for future growth. Semperit reported an EBITDA of EUR 71.8 million, down by 28.5%, and a positive earnings after tax from continued operations at EUR 24.9 million, a decline of 35.2%.

Cost-cutting measures have started to bear fruit, saving more than EUR 10 million annually, with EUR 5.8 million impacting 2023's earnings. The company anticipates an EBITDA of approximately EUR 80 million in 2024 and will propose a dividend of EUR 0.5 per share. Semperit's transformation year has seen it reposition as an elastomer specialist in the industrial sector, bolstered by the acquisition of liquid silicone expert Rico. Despite ongoing economic pressures and reduced demand in some sectors, the company remains optimistic about its growth prospects and financial stability, with a robust equity ratio of 45.3% and planned investments in expanding its industrial applications division.